Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 718

1.

Cost Conversations Between Primary Care Providers and Patients with Expanded Medicaid Coverage.

Tipirneni R, Patel MR, Kirch MA, Goold SD.

J Gen Intern Med. 2018 Jul 11. doi: 10.1007/s11606-018-4551-2. [Epub ahead of print] No abstract available.

PMID:
29998433
2.

Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.

Berger JS, Abramson BL, Lopes RD, Heizer G, Rockhold FW, Baumgartner I, Fowkes FGR, Held P, Katona BG, Norgren L, Jones WS, Millegård M, Blomster J, Reist C, Hiatt WR, Patel MR, Mahaffey KW; EUCLID Trial Steering Committee and Investigators.

Vasc Med. 2018 Jul 1:1358863X18775594. doi: 10.1177/1358863X18775594. [Epub ahead of print]

PMID:
29992857
3.

Radiographic Imaging Does Not Reliably Predict Macroscopic Extranodal Extension in Human Papilloma Virus-Associated Oropharyngeal Cancer.

Patel MR, Hudgins PA, Beitler JJ, Magliocca KR, Griffith CC, Liu Y, Bougnon K, El-Deiry M, Saba NF, Aiken AH.

ORL J Otorhinolaryngol Relat Spec. 2018 Jul 3;80(2):85-95. doi: 10.1159/000487239. [Epub ahead of print]

PMID:
29969771
4.

Direct-acting Antiviral Agents in Hepatitis C Virus-infected Renal Allograft Recipients: Treatment and Outcome Experience from Single Center.

Prasad N, Patel MR, Pandey A, Jaiswal A, Bhadauria D, Kaul A, Sharma RK, Mohindra S, Pandey G, Goel A, Gupta A.

Indian J Nephrol. 2018 May-Jun;28(3):220-225. doi: 10.4103/ijn.IJN_190_17.

5.

Odyssey of Patent Foramen Ovale: Closure in Cryptogenic Stroke: The Canary in the Coal Mine of Clinical Trials?

Vemulapalli S, Patel MR.

J Am Heart Assoc. 2018 Jun 17;7(12). pii: e009558. doi: 10.1161/JAHA.118.009558. No abstract available.

6.

Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome.

Inohara T, Pieper K, Wojdyla DM, Patel MR, Jones WS, Tricoci P, Mahaffey KW, James SK, Alexander JH, Lopes RD, Wallentin L, Ohman EM, Roe MT, Vemulapalli S.

Am Heart J. 2018 Jul;201:25-32. doi: 10.1016/j.ahj.2018.03.013. Epub 2018 Mar 28.

PMID:
29910052
7.

Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF.

Chen ST, Hellkamp AS, Becker RC, Berkowitz SD, Breithardt G, Fox KAA, Hacke W, Halperin JL, Hankey GJ, Mahaffey KW, Nessel CC, Piccini JP, Singer DE, Patel MR.

Am Heart J. 2018 Jun;200:102-109. doi: 10.1016/j.ahj.2018.02.013. Epub 2018 Feb 27.

PMID:
29898836
8.

Splanchnic Nerve Block for Acute Heart Failure.

Fudim M, Jones WS, Boortz-Marx RL, Ganesh A, Green CL, Hernandez AF, Patel MR.

Circulation. 2018 May 25. pii: CIRCULATIONAHA.118.035260. doi: 10.1161/CIRCULATIONAHA.118.035260. [Epub ahead of print]

PMID:
29804067
9.

Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors.

Shapiro GI, Kristeleit RS, Burris HA, LoRusso P, Patel MR, Drew Y, Giordano H, Maloney L, Watkins S, Goble S, Jaw-Tsai S, Xiao JJ.

Clin Pharmacol Drug Dev. 2018 May 25. doi: 10.1002/cpdd.575. [Epub ahead of print]

PMID:
29799676
10.

Phase II Study of Taselisib (GDC‑0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer.

Dickler MN, Saura C, Richards D, Krop I, Cervantes A, Bedard PL, Patel MR, Pusztai L, Oliveira M, Cardenas AK, Cui N, Wilson TR, Stout TJ, Wei MC, Hsu JY, Baselga J.

Clin Cancer Res. 2018 May 23. pii: clincanres.0613.2018. doi: 10.1158/1078-0432.CCR-18-0613. [Epub ahead of print]

PMID:
29793946
11.

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).

Capell WH, Bonaca MP, Nehler MR, Chen E, Kittelson JM, Anand SS, Berkowitz SD, Debus ES, Fanelli F, Haskell L, Patel MR, Bauersachs R, Hiatt WR.

Am Heart J. 2018 May;199:83-91. doi: 10.1016/j.ahj.2018.01.011. Epub 2018 Feb 3.

PMID:
29754671
12.

A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumors.

Bauer TM, Patel MR, Forero-Torres A, George TJ Jr, Assad A, Du Y, Hurwitz H.

Onco Targets Ther. 2018 Apr 30;11:2399-2407. doi: 10.2147/OTT.S157331. eCollection 2018.

13.

Correction to: ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease.

Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, Smith PK.

J Nucl Cardiol. 2018 May 10. doi: 10.1007/s12350-018-1292-x. [Epub ahead of print]

PMID:
29748874
14.

Mature Technology for Mature Patients: The Increasing Complexities of Patients Treated With Coronary Angiography and Interventions.

Rymer JA, Patel MR.

JACC Cardiovasc Interv. 2018 May 14;11(9):889-891. doi: 10.1016/j.jcin.2018.03.032. No abstract available.

PMID:
29747920
15.

Should a Meta-Analysis Guide Our Practice?

Ohman EM, Patel MR.

JACC Cardiovasc Interv. 2018 May 14;11(9):844-846. doi: 10.1016/j.jcin.2018.03.033. No abstract available.

PMID:
29747914
16.

Vascular Endothelial Growth Factor Gene Polymorphism Is Associated With Long-term Kidney Allograft Outcomes.

Prakash S, Patel MR, Agrawal S, Jindal RM, Prasad N.

Kidney Int Rep. 2017 Oct 24;3(2):321-327. doi: 10.1016/j.ekir.2017.10.008. eCollection 2018 Mar.

17.

Screening for Poverty and Poverty-Related Social Determinants of Health.

Berman RS, Patel MR, Belamarich PF, Gross RS.

Pediatr Rev. 2018 May;39(5):235-246. doi: 10.1542/pir.2017-0123. No abstract available. Erratum in: Pediatr Rev. 2018 Jul;39(7):374.

PMID:
29716966
18.

Does cross-cultural communication training for physicians improve pediatric asthma outcomes? A randomized trial.

Patel MR, Song PXK, Bruzzese JM, Hao W, Evans D, Thomas LJ, Pinkett-Heller M, Meyerson K, Brown RW.

J Asthma. 2018 Apr 11:1-12. doi: 10.1080/02770903.2018.1455856. [Epub ahead of print]

PMID:
29641357
19.

Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution.

Rogers RK, Hiatt WR, Patel MR, Shishehbor MH, White R, Khan ND, Bhalla NP, Jones WS, Low Wang CC.

Vasc Med. 2018 Apr 1:1358863X18760996. doi: 10.1177/1358863X18760996. [Epub ahead of print]

PMID:
29629845
20.

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.

Wrangle JM, Velcheti V, Patel MR, Garrett-Mayer E, Hill EG, Ravenel JG, Miller JS, Farhad M, Anderton K, Lindsey K, Taffaro-Neskey M, Sherman C, Suriano S, Swiderska-Syn M, Sion A, Harris J, Edwards AR, Rytlewski JA, Sanders CM, Yusko EC, Robinson MD, Krieg C, Redmond WL, Egan JO, Rhode PR, Jeng EK, Rock AD, Wong HC, Rubinstein MP.

Lancet Oncol. 2018 May;19(5):694-704. doi: 10.1016/S1470-2045(18)30148-7. Epub 2018 Apr 5.

PMID:
29628312
21.

Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation.

Patel MR, Peacock WF, Tamayo S, Sicignano N, Hopf KP, Yuan Z.

Clin Exp Emerg Med. 2018 Mar 30;5(1):43-50. doi: 10.15441/ceem.17.216. eCollection 2018 Mar.

22.

High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial.

Januzzi JL Jr, Suchindran S, Coles A, Ferencik M, Patel MR, Hoffmann U, Ginsburg GS, Douglas PS; PROMISE Investigators.

JACC Cardiovasc Imaging. 2018 Mar 9. pii: S1936-878X(18)30132-3. doi: 10.1016/j.jcmg.2018.01.021. [Epub ahead of print]

PMID:
29550314
23.

Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF.

Barnett AS, Cyr DD, Goodman SG, Levitan BS, Yuan Z, Hankey GJ, Singer DE, Becker RC, Breithardt G, Berkowitz SD, Halperin JL, Hacke W, Mahaffey KW, Nessel CC, Fox KAA, Patel MR, Piccini JP.

Int J Cardiol. 2018 Apr 15;257:78-83. doi: 10.1016/j.ijcard.2017.06.110.

PMID:
29506743
24.

Malnutrition Identified by the Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition Consensus Criteria and Other Bedside Tools Is Highly Prevalent in a Sample of Individuals Undergoing Treatment for Head and Neck Cancer.

Mulasi U, Vock DM, Kuchnia AJ, Jha G, Fujioka N, Rudrapatna V, Patel MR, Teigen L, Earthman CP.

JPEN J Parenter Enteral Nutr. 2018 Jan;42(1):139-147. doi: 10.1177/0148607116672264. Epub 2017 Dec 11.

PMID:
29505143
25.

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study.

Burris HA 3rd, Flinn IW, Patel MR, Fenske TS, Deng C, Brander DM, Gutierrez M, Essell JH, Kuhn JG, Miskin HP, Sportelli P, Weiss MS, Vakkalanka S, Savona MR, O'Connor OA.

Lancet Oncol. 2018 Apr;19(4):486-496. doi: 10.1016/S1470-2045(18)30082-2. Epub 2018 Feb 20.

PMID:
29475723
26.

Immunotherapy for thoracic oncology gone viral.

Patel MR.

Immunotherapy. 2018 Apr;10(5):383-390. doi: 10.2217/imt-2017-0148.

PMID:
29473469
27.

ACC Appropriate Use Criteria Methodology: 2018 Update: A Report of the American College of Cardiology Appropriate Use Criteria Task Force.

Hendel RC, Lindsay BD, Allen JM, Brindis RG, Patel MR, White L, Winchester DE, Wolk MJ.

J Am Coll Cardiol. 2018 Feb 27;71(8):935-948. doi: 10.1016/j.jacc.2018.01.007. No abstract available.

PMID:
29471942
28.

Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry.

DeVore AD, Hammill BG, Patel CB, Patel MR, Rogers JG, Milano CA, Hernandez AF.

ASAIO J. 2018 Mar/Apr;64(2):218-224. doi: 10.1097/MAT.0000000000000629.

PMID:
29470245
29.

Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials.

Kelly K, Infante JR, Taylor MH, Patel MR, Wong DJ, Iannotti N, Mehnert JM, Loos AH, Koch H, Speit I, Gulley JL.

Cancer. 2018 May 1;124(9):2010-2017. doi: 10.1002/cncr.31293. Epub 2018 Feb 22.

30.

Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours.

Moore KN, Bauer TM, Falchook GS, Chowdhury S, Patel C, Neuwirth R, Enke A, Zohren F, Patel MR.

ESMO Open. 2018 Feb 1;3(2):e000291. doi: 10.1136/esmoopen-2017-000291. eCollection 2018.

31.

A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma.

Steuer CE, Griffith CC, Nannapaneni S, Patel MR, Liu Y, Magliocca KR, El-Deiry MW, Cohen C, Owonikoko TK, Shin DM, Chen ZG, Saba NF.

Mol Cancer Ther. 2018 Mar;17(3):710-716. doi: 10.1158/1535-7163.MCT-17-0504. Epub 2018 Feb 13.

PMID:
29440293
32.

A First-in-Human Study of the New Oral Selective Estrogen Receptor Degrader AZD9496 for ER+/HER2- Advanced Breast Cancer.

Hamilton EP, Patel MR, Armstrong AC, Baird RD, Jhaveri K, Hoch M, Klinowska T, Lindemann JPO, Morgan SR, Schiavon G, Weir HM, Im SA.

Clin Cancer Res. 2018 Feb 13. doi: 10.1158/1078-0432.CCR-17-3102. [Epub ahead of print]

PMID:
29440181
33.

Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia.

Yun S, Zhang L, Patel MR, Knepper TC, Chavez JC, Pinilla-Ibarz J.

Blood. 2018 Mar 15;131(11):1258-1261. doi: 10.1182/blood-2017-11-819276. Epub 2018 Feb 5. No abstract available.

PMID:
29437555
34.

Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention: An Analysis From the National Cardiovascular Data Registry.

Washam JB, Kaltenbach LA, Wojdyla DM, Patel MR, Klein AJ, Abbott JD, Rao SV.

Circ Cardiovasc Interv. 2018 Feb;11(2):e005628. doi: 10.1161/CIRCINTERVENTIONS.117.005628.

PMID:
29432119
35.

Incidence and predictors of lesion-specific ischemia by FFRCT: Learnings from the international ADVANCE registry.

Kitabata H, Leipsic J, Patel MR, Nieman K, De Bruyne B, Rogers C, Pontone G, Nørgaard BL, Bax JJ, Raff G, Chinnaiyan KM, Rabbat M, Rønnow Sand NP, Blanke P, Fairbairn TA, Matsuo H, Amano T, Kawasaki T, Morino Y, Akasaka T.

J Cardiovasc Comput Tomogr. 2018 Mar - Apr;12(2):95-100. doi: 10.1016/j.jcct.2018.01.008. Epub 2018 Feb 2.

PMID:
29422416
36.

Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial.

Kochar A, Hellkamp AS, Lokhnygina Y, Jones WS, Becker RC, Berkowitz SD, Breithardt G, Fox KAA, Halperin JL, Hankey GJ, Mahaffey KW, Nessel CC, Singer DE, Piccini JP, Patel MR.

Clin Cardiol. 2018 Jan;41(1):39-45. doi: 10.1002/clc.22846. Epub 2018 Feb 1.

37.

Antithrombotic therapy in peripheral artery disease: A review of the EUCLID trial results and current ongoing trials.

Ward R, Long C, Patel MR, Jones WS.

Clin Cardiol. 2018 Jan;41(1):137-143. doi: 10.1002/clc.22839. Epub 2018 Jan 22. Review.

38.

Antithrombotic Therapy in Peripheral Artery Disease: Generating and Translating Evidence Into Practice.

Jones WS, Patel MR.

J Am Coll Cardiol. 2018 Jan 23;71(3):352-362. doi: 10.1016/j.jacc.2017.11.021. Review.

PMID:
29348028
39.

Comparison of Anticoagulant Therapy for Atrial Fibrillation - Novel Oral Anticoagulants Versus Vitamin K Antagonists.

Chen ST, Patel MR.

Prog Cardiovasc Dis. 2018 Jan - Feb;60(4-5):514-523. doi: 10.1016/j.pcad.2018.01.005. Epub 2018 Jan 13. Review.

PMID:
29339167
40.

Neurology of renal disorders.

Patel MR, Gupta A.

Neurol India. 2018 Jan-Feb;66(1):55-56. doi: 10.4103/0028-3886.222828. No abstract available.

41.

The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer.

Moore K, Zhang ZY, Agarwal S, Burris H, Patel MR, Kansra V.

Cancer Chemother Pharmacol. 2018 Mar;81(3):497-503. doi: 10.1007/s00280-017-3512-5. Epub 2018 Jan 10.

PMID:
29322231
42.

Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial.

Ferencik M, Mayrhofer T, Bittner DO, Emami H, Puchner SB, Lu MT, Meyersohn NM, Ivanov AV, Adami EC, Patel MR, Mark DB, Udelson JE, Lee KL, Douglas PS, Hoffmann U.

JAMA Cardiol. 2018 Feb 1;3(2):144-152. doi: 10.1001/jamacardio.2017.4973.

PMID:
29322167
43.

Early versus late institution of plasma exchange therapy in pregnancy induced thrombotic microangiopathy and its effects on clinical outcomes-A case series.

Kaul A, Vishwakarma K, Bhaduaria DS, Mishra P, Prasad N, Jain M, Thammshetti V, Patel MR, Gupta A, Sharma RK.

Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:129-134. doi: 10.1016/j.ejogrb.2017.12.020. Epub 2017 Dec 21.

PMID:
29288923
44.

Multiple injections per injection episode: High-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana.

Broz D, Zibbell J, Foote C, Roseberry JC, Patel MR, Conrad C, Chapman E, Peters PJ, Needle R, McAlister C, Duwve JM.

Int J Drug Policy. 2018 Feb;52:97-101. doi: 10.1016/j.drugpo.2017.12.003. Epub 2017 Dec 24.

PMID:
29278838
45.

Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.

Norgren L, Patel MR, Hiatt WR, Wojdyla DM, Fowkes FGR, Baumgartner I, Mahaffey KW, Berger JS, Jones WS, Katona BG, Held P, Blomster JI, Rockhold FW, Björck M; EUCLID Steering Committee and Investigators.

Eur J Vasc Endovasc Surg. 2018 Jan;55(1):109-117. doi: 10.1016/j.ejvs.2017.11.006. Epub 2017 Dec 20.

PMID:
29273390
46.

Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak.

Patel MR, Foote C, Duwve J, Chapman E, Combs B, Fry A, Hall P, Roseberry J, Brooks JT, Broz D.

J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):373-382. doi: 10.1097/QAI.0000000000001615.

PMID:
29271829
47.

ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.

Aortic Stenosis Writing Group, Bonow RO, Brown AS, Gillam LD, Kapadia SR, Kavinsky CJ, Lindman BR, Mack MJ, Thourani VH; Aortic Stenosis Rating Panel, Dehmer GJ, Bonow RO, Lindman BR, Beaver TM, Bradley SM, Carabello BA, Desai MY, George I, Green P, Holmes DR Jr, Johnston D, Leipsic J, Mick SL, Passeri JJ, Piana RN, Reichek N, Ruiz CE, Taub CC, Thomas JD, Turi ZG; Appropriate Use Criteria Task Force, Doherty JU, Dehmer GJ, Bailey SR, Bhave NM, Brown AS, Daugherty SL, Dean LS, Desai MY, Duvernoy CS, Gillam LD, Hendel RC, Kramer CM, Lindsay BD, Manning WJ, Mehrotra P, Patel MR, Sachdeva R, Wann LS, Winchester DE, Allen JM.

J Am Soc Echocardiogr. 2018 Feb;31(2):117-147. doi: 10.1016/j.echo.2017.10.020. Epub 2017 Dec 16.

PMID:
29254695
48.

First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study.

Sullivan RJ, Infante JR, Janku F, Wong DJL, Sosman JA, Keedy V, Patel MR, Shapiro GI, Mier JW, Tolcher AW, Wang-Gillam A, Sznol M, Flaherty K, Buchbinder E, Carvajal RD, Varghese AM, Lacouture ME, Ribas A, Patel SP, DeCrescenzo GA, Emery CM, Groover AL, Saha S, Varterasian M, Welsch DJ, Hyman DM, Li BT.

Cancer Discov. 2018 Feb;8(2):184-195. doi: 10.1158/2159-8290.CD-17-1119. Epub 2017 Dec 15.

PMID:
29247021
49.

Predicting risk of cardiac events among ST-segment elevation myocardial infarction patients with conservatively managed non-infarct-related artery coronary artery disease: An analysis of the Duke Databank for Cardiovascular Disease.

Hirji SA, Stevens SR, Shaw LK, Campbell EC, Granger CB, Patel MR, Sketch MH Jr, Wang TY, Ohman EM, Peterson ED, Brennan JM.

Am Heart J. 2017 Dec;194:116-124. doi: 10.1016/j.ahj.2017.08.023. Epub 2017 Sep 1.

PMID:
29223429
50.

Making Time for Patients: Positive Impact of Direct Patient Reporting.

Mohan SK, Hudgins PA, Patel MR, Stapleton J, Duszak R Jr, Aiken AH.

AJR Am J Roentgenol. 2018 Jan;210(1):W12-W17. doi: 10.2214/AJR.17.18327. Epub 2017 Dec 8.

PMID:
29220209

Supplemental Content

Loading ...
Support Center